A.KastenT
Es un tratamiento crnico mientras aporte beneficio y sea seguro: el mdico revisa tu respuesta cada 3 meses y decide contigo si continuar, ajustar o suspender
Dual GIP and GLP-1 drugs target multiple pathways that influence appetite regulation and metabolism
However, some may experience side effects
Brajan Budini, a medical student at the School of Clinical Medicine and Trinity College, University of Cambridge, said: Drugs such as Ozempic and Wegovy act like brakes on our appetite, making us feel full sooner, which means we eat less and therefore lose weight
This unique pharmacokinetic characteristic thoroughly supports detailed, long-term studies of hormonal timing, metabolic feedback mechanisms, and endocrine adaptation